William McGlashan

Bill is a founding Partner of TPG Growth, the growth equity and smaller buyout investment platform of TPG, the global private investment firm. With more than $2 billion under management, TPG Growth targets investments in technology, life sciences, renewables and consumer companies utilizing growth equity, public equity and leveraged buyout structures. Prior to joining TPG in 2004, Bill was the Chairman and CEO of Critical Path (NASDAQ: CPTH). He joined Critical Path in April of 2001 to undertake a major financial and operational restructuring of the company. Previously, he co-founded and served as Chief Executive Officer of Vectis Group, a venture corporation that capitalized and built companies in emerging markets, in partnership with leading U.S. technology businesses. Bill also co-founded and served as President of Pharmanex Inc., a leading phyto-pharmaceutical and dietary supplement company with annual sales of approximately $500 million in 20 countries and significant operations in the People’s Republic of China. The company was sold to NSE (NYSE: NUS) in 1999. Prior to Pharmanex, he was a senior associate with Bain Capital and Information Partners. Bill earned a BA with honors from Yale University and an MBA from the Stanford Graduate School of Business. He is a member of Young Presidents’ Organization in the San Francisco Barbary Coast chapter, and serves on the Advisory Council for the Yale School of Management as well as the Boards of XOJet, David’s Bridal, AgraQuest, SuccessFactors, Elevance, the Bay Area Discovery Museum and Backroads.